OFCC1 Inhibitors
Chemical inhibitors of OFCC1 operate through the modulation of kinase activity, which is essential for the phosphorylation processes that regulate OFCC1 function. Alsterpaullone, a compound known for its role in inhibiting cyclin-dependent kinases (CDKs), can lead to reduced activity of OFCC1 by impeding the phosphorylation signals integral to cell cycle regulation. Similarly, Palbociclib and PD0332991, both targeting CDK4 and CDK6, can decrease the activity of OFCC1 by altering cell cycle-related signaling pathways. Roscovitine, with its affinity for CDK2, CDK7, and CDK9, and Dinaciclib, a potent CDK inhibitor, can also contribute to the decrease in OFCC1 activity through the down-regulation of phosphorylation events. Flavopiridol extends this list by inhibiting several CDKs, further influencing the phosphorylation status of OFCC1.
The action of Olomoucine, another selective inhibitor of CDKs, can result in the inhibition of phosphorylation events necessary for OFCC1 function, thereby reducing its activity. Indirubin-3'-monoxime, which inhibits CDKs and GSK-3β, can impact the Wnt signaling pathway that OFCC1 is involved in, leading to alterations in OFCC1 activity. SNS-032, selective for CDKs 2, 7, and 9, can similarly decrease OFCC1 activity due to reduced phosphorylation. Milciclib, which targets multiple CDKs, can inhibit OFCC1 by limiting phosphorylation-dependent signals. Lastly, Ribociclib and Abemaciclib, both selective inhibitors of CDK4 and CDK6, can lead to cell cycle arrest, which in turn can reduce the activity of OFCC1 by affecting kinase-dependent pathways that regulate its function. Each of these chemical inhibitors interacts with the kinases in a manner that can lead to reduced OFCC1 activity through diminished phosphorylation.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Aphidicolin | 38966-21-1 | sc-201535 sc-201535A sc-201535B | 1 mg 5 mg 25 mg | $84.00 $306.00 $1104.00 | 30 | |
Aphidicolin inhibits DNA polymerase, which is essential for DNA replication. By inhibiting DNA replication, it indirectly inhibits OBFC2B's role in DNA replication and repair pathways since OBFC2B is involved in stabilizing replication forks. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide stabilizes the DNA topoisomerase II complex after it breaks the DNA strand for replication, preventing the ligation of the DNA strands. This leads to inhibition of DNA replication and indirectly inhibits OBFC2B function which is involved in DNA repair and replication. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin inhibits DNA topoisomerase I, leading to DNA damage during replication. OBFC2B, which plays a role in DNA repair, is indirectly inhibited as the increased DNA damage overwhelms the repair mechanisms. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D binds to DNA and prevents RNA synthesis by RNA polymerase. This inhibits transcription and indirectly inhibits OBFC2B by limiting the nucleoprotein complex formation it requires for proper function in DNA stabilization. | ||||||
Mitoxantrone | 65271-80-9 | sc-207888 | 100 mg | $285.00 | 8 | |
Mitoxantrone intercalates into DNA and inhibits topoisomerase II, leading to DNA damage and apoptosis. This indirectly inhibits OBFC2B's function in DNA repair as the damage accrues. | ||||||
Amsacrine hydrochloride | 54301-15-4 | sc-214540 | 10 mg | $232.00 | ||
Amsacrine is a topoisomerase II inhibitor that disrupts DNA synthesis and function, indirectly inhibiting OBFC2B's DNA repair and replication activities. | ||||||
Bleomycin | 11056-06-7 | sc-507293 | 5 mg | $275.00 | 5 | |
Bleomycin causes DNA strand breaks by free radical formation, which indirectly inhibits OBFC2B's role in DNA repair since it is involved in the processing of stalled replication forks. | ||||||
Daunorubicin hydrochloride | 23541-50-6 | sc-200921 sc-200921A sc-200921B sc-200921C | 10 mg 50 mg 250 mg 1 g | $105.00 $438.00 $837.00 $1569.00 | 4 | |
Daunorubicin intercalates into DNA and inhibits the progression of topoisomerase II, leading to DNA breaks. OBFC2B's function is indirectly inhibited as it is unable to adequately address the increased DNA damage. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin intercalates into DNA and disrupts topoisomerase II's DNA-relaxing function, causing DNA damage and indirectly inhibiting OBFC2B's DNA repair function. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Hydroxyurea inhibits ribonucleotide reductase, decreasing the pool of deoxyribonucleotides available for DNA synthesis, indirectly inhibiting OBFC2B activity in DNA replication. | ||||||